Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426564 · ClinicalTrials.gov registry record
Exploratory Assessment of the Quantra® System in Adult ECMO Patients
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 10
- Enrollment target
NCT05426564: Completed study, sponsored by HemoSonics.
NCT05426564 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05426564 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This is a prospective, observational exploratory study of the performance of the Quantra System in adult patients that are undergoing an arterio-venous (AV), veno-venous (VV) ECMO or extra-corporeal life support (ECLS) procedure.
Primary Outcome
Coagulation function assessed by Quantra and standard-of-care coagulation tests
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-09-27 |
| Est. Completion | 2023-06-01 |
What the finished NCT05426564 record still lists
NCT05426564 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT05426564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05426564 about?
NCT05426564 is a clinical study titled "Exploratory Assessment of the Quantra® System in Adult ECMO Patients". This is a prospective, observational exploratory study of the performance of the Quantra System in adult patients that are undergoing an arterio-venous (AV), veno-venous (VV) ECMO or extra-corporeal life support (ECLS) procedure.
What is the current status of trial NCT05426564?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-09-27. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT05426564?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05426564?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI